Boris Juelg, MD PhD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults (NCT04983030) | Boris Juelg, MD PhD | 2022-04-01 |
Track Boris Juelg, MD PhD automatically
Every clearance here is in the API, with alerts when new ones post.